Prevalência de sequelas neurológicas em pacientes pós-acometimento por COVID-19
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Tipo de documento: | Trabalho de conclusão de curso |
Idioma: | por |
Título da fonte: | Repositório Institucional da UFAM |
Texto Completo: | http://riu.ufam.edu.br/handle/prefix/6308 |
Resumo: | Introduction: COVID-19 is an infectious disease caused by SARS-COV-2, which is characterized by a high degree of contagion and a wide range of clinical manifestations that can be mild, moderate and intense, affecting different organs and systems, including these the nervous system, due to its characteristics of neurotropism. Recently, the existence of long-term effects in already infected individuals has been confirmed, however these effects are not fully understood, ranging from headaches or body aches to limitations in functionality. Methods: Prospective cross-sectional observational study, which investigated the presence of neuropsychiatric symptoms and level of functionality in adult individuals already affected by COVID-19, through the application of a PRO questionnaire and functionality scale on an online platform. Results: 62 adult individuals of both sexes, already infected with SARS-COV-2 participated in this study, mostly young women, the incidence percentages of the most reported symptoms were headache 37.7%, anxiety 41.9% and confusion /lack of concentration 29.0%, 46.8% of the participants have severe functionality limitations, in the crossing of the proportion of symptoms and vaccine doses taken, there was no relationship of the number of doses for all symptoms, but for the relationship of impairment of functionality and presence or absence of symptoms for anxiety (p<0.001), for depression (p=0.009), for confusion/lack of concentration (p=0.008) and dizziness (p=0.049). Conclusion: The most frequently reported symptoms were headache, anxiety and confusion / lack of concentration, almost half of the participants had severe functionality limitations and there is a statistically significant difference when relating the level of functionality impairment with the symptoms of anxiety, depression, confusion/high concentration and dizziness in addition, the number of vaccine doses does not interfere with the presence or absence of symptoms in these patients. |
id |
UFAM-1_97b62b4c5423a0a83116e01f716c9778 |
---|---|
oai_identifier_str |
oai:localhost:prefix/6308 |
network_acronym_str |
UFAM-1 |
network_name_str |
Repositório Institucional da UFAM |
repository_id_str |
|
spelling |
Prevalência de sequelas neurológicas em pacientes pós-acometimento por COVID-19Pós-covid-19Sintomas neurológicosPrevalênciaAnsiedadeFuncionalidadeCIENCIAS DA SAUDE: FISIOTERAPIA E TERAPIA OCUPACIONALCOVID-19, Pandemia de, 2020-COVID-19 (Doença)Introduction: COVID-19 is an infectious disease caused by SARS-COV-2, which is characterized by a high degree of contagion and a wide range of clinical manifestations that can be mild, moderate and intense, affecting different organs and systems, including these the nervous system, due to its characteristics of neurotropism. Recently, the existence of long-term effects in already infected individuals has been confirmed, however these effects are not fully understood, ranging from headaches or body aches to limitations in functionality. Methods: Prospective cross-sectional observational study, which investigated the presence of neuropsychiatric symptoms and level of functionality in adult individuals already affected by COVID-19, through the application of a PRO questionnaire and functionality scale on an online platform. Results: 62 adult individuals of both sexes, already infected with SARS-COV-2 participated in this study, mostly young women, the incidence percentages of the most reported symptoms were headache 37.7%, anxiety 41.9% and confusion /lack of concentration 29.0%, 46.8% of the participants have severe functionality limitations, in the crossing of the proportion of symptoms and vaccine doses taken, there was no relationship of the number of doses for all symptoms, but for the relationship of impairment of functionality and presence or absence of symptoms for anxiety (p<0.001), for depression (p=0.009), for confusion/lack of concentration (p=0.008) and dizziness (p=0.049). Conclusion: The most frequently reported symptoms were headache, anxiety and confusion / lack of concentration, almost half of the participants had severe functionality limitations and there is a statistically significant difference when relating the level of functionality impairment with the symptoms of anxiety, depression, confusion/high concentration and dizziness in addition, the number of vaccine doses does not interfere with the presence or absence of symptoms in these patients.Introdução: A COVID-19 é uma doença infecciosa causada pelo SARS-COV-2, que se caracteriza por alto grau de contagio e grande variação de manifestações clínicas que podem ser leves, moderadas e intensas, e que afeta diferentes órgãos e sistemas, dentre estes o sistema nervoso, devido suas características de neurotropismo. Recentemente, confirmou-se a existência de efeitos à longo prazo em indivíduos já infectados, no entanto estes efeitos não são totalmente esclarecidos, podendo ir de dores de cabeça ou no corpo até limitações na funcionalidade. Métodos: Estudo prospectivo transversal de caráter observacional, onde investigou-se a presença de sintomas neuropsiquiátricos e nível de funcionalidade em indivíduos adultos já acometidos por COVID-19, por meio de aplicação de questionário PRO e escala de funcionalidade em plataforma online. Resultados: 62 indivíduos adultos de ambos os sexos, já infectados pelo SARS-COV-2 participaram deste estudo, sendo em sua maioria mulheres jovens, as porcentagens de incidência dos sintomas mais relatados foram, dor de cabeça 37.7%, ansiedade 41.9% e confusão/falta de concentração 29.0%, 46.8% dos participantes apresentam limitações de funcionalidade graves, no cruzamento de proporção de sintomas e doses de vacina tomadas, não houve relação do número de doses para todos os sintomas, mas para a relação de acometimento da funcionalidade e presença ou ausência de sintomas para ansiedade (p<0.001), para depressão (p=0.009), para confusão/falta de concentração (p=0.008) e tontura (p=0.049). Conclusão: Os sintomas relatados com maior frequência foram dor de cabeça, ansiedade e confusão / falta de concentração, quase metade dos participantes apresentaram limitações de funcionalidade graves e há diferença significativamente estatística ao relacionar nível de acometimento de funcionalidade com os sintomas de ansiedade, depressão, confusão/ alta de concentração e tontura além de, a quantidade de doses de vacina não interferir na presença ou ausência de sintomas destes pacientes.2Sem sugestões para o momento.NãoBrasilISB - Instituto de Saúde e Biotecnologia (Coari)Coari (AM)Fisioterapia - Bacharelado - CoariReis, Rafael de Menezeshttp://lattes.cnpq.br/3766681056482554Maciel, Thiago dos Santoshttp://lattes.cnpq.br/4136986758835205Mori, Brunohttp://lattes.cnpq.br/4237392698166152https://orcid.org/0000-0002-8496-5939https://orcid.org/0000-0002-8496-5939https://orcid.org/0000-0003-0903-2132Canto, Claudia Melo2022-09-27T16:52:58Z2022-09-162022-09-27T16:52:58Z2022-08-29info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesishttp://riu.ufam.edu.br/handle/prefix/6308porinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFAMinstname:Universidade Federal do Amazonas (UFAM)instacron:UFAM2023-10-30T14:08:49Zoai:localhost:prefix/6308Repositório InstitucionalPUBhttp://riu.ufam.edu.br/oai/requestopendoar:2023-10-30T14:08:49Repositório Institucional da UFAM - Universidade Federal do Amazonas (UFAM)false |
dc.title.none.fl_str_mv |
Prevalência de sequelas neurológicas em pacientes pós-acometimento por COVID-19 |
title |
Prevalência de sequelas neurológicas em pacientes pós-acometimento por COVID-19 |
spellingShingle |
Prevalência de sequelas neurológicas em pacientes pós-acometimento por COVID-19 Canto, Claudia Melo Pós-covid-19 Sintomas neurológicos Prevalência Ansiedade Funcionalidade CIENCIAS DA SAUDE: FISIOTERAPIA E TERAPIA OCUPACIONAL COVID-19, Pandemia de, 2020- COVID-19 (Doença) |
title_short |
Prevalência de sequelas neurológicas em pacientes pós-acometimento por COVID-19 |
title_full |
Prevalência de sequelas neurológicas em pacientes pós-acometimento por COVID-19 |
title_fullStr |
Prevalência de sequelas neurológicas em pacientes pós-acometimento por COVID-19 |
title_full_unstemmed |
Prevalência de sequelas neurológicas em pacientes pós-acometimento por COVID-19 |
title_sort |
Prevalência de sequelas neurológicas em pacientes pós-acometimento por COVID-19 |
author |
Canto, Claudia Melo |
author_facet |
Canto, Claudia Melo |
author_role |
author |
dc.contributor.none.fl_str_mv |
Reis, Rafael de Menezes http://lattes.cnpq.br/3766681056482554 Maciel, Thiago dos Santos http://lattes.cnpq.br/4136986758835205 Mori, Bruno http://lattes.cnpq.br/4237392698166152 https://orcid.org/0000-0002-8496-5939 https://orcid.org/0000-0002-8496-5939 https://orcid.org/0000-0003-0903-2132 |
dc.contributor.author.fl_str_mv |
Canto, Claudia Melo |
dc.subject.por.fl_str_mv |
Pós-covid-19 Sintomas neurológicos Prevalência Ansiedade Funcionalidade CIENCIAS DA SAUDE: FISIOTERAPIA E TERAPIA OCUPACIONAL COVID-19, Pandemia de, 2020- COVID-19 (Doença) |
topic |
Pós-covid-19 Sintomas neurológicos Prevalência Ansiedade Funcionalidade CIENCIAS DA SAUDE: FISIOTERAPIA E TERAPIA OCUPACIONAL COVID-19, Pandemia de, 2020- COVID-19 (Doença) |
description |
Introduction: COVID-19 is an infectious disease caused by SARS-COV-2, which is characterized by a high degree of contagion and a wide range of clinical manifestations that can be mild, moderate and intense, affecting different organs and systems, including these the nervous system, due to its characteristics of neurotropism. Recently, the existence of long-term effects in already infected individuals has been confirmed, however these effects are not fully understood, ranging from headaches or body aches to limitations in functionality. Methods: Prospective cross-sectional observational study, which investigated the presence of neuropsychiatric symptoms and level of functionality in adult individuals already affected by COVID-19, through the application of a PRO questionnaire and functionality scale on an online platform. Results: 62 adult individuals of both sexes, already infected with SARS-COV-2 participated in this study, mostly young women, the incidence percentages of the most reported symptoms were headache 37.7%, anxiety 41.9% and confusion /lack of concentration 29.0%, 46.8% of the participants have severe functionality limitations, in the crossing of the proportion of symptoms and vaccine doses taken, there was no relationship of the number of doses for all symptoms, but for the relationship of impairment of functionality and presence or absence of symptoms for anxiety (p<0.001), for depression (p=0.009), for confusion/lack of concentration (p=0.008) and dizziness (p=0.049). Conclusion: The most frequently reported symptoms were headache, anxiety and confusion / lack of concentration, almost half of the participants had severe functionality limitations and there is a statistically significant difference when relating the level of functionality impairment with the symptoms of anxiety, depression, confusion/high concentration and dizziness in addition, the number of vaccine doses does not interfere with the presence or absence of symptoms in these patients. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-09-27T16:52:58Z 2022-09-16 2022-09-27T16:52:58Z 2022-08-29 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
format |
bachelorThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://riu.ufam.edu.br/handle/prefix/6308 |
url |
http://riu.ufam.edu.br/handle/prefix/6308 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Brasil ISB - Instituto de Saúde e Biotecnologia (Coari) Coari (AM) Fisioterapia - Bacharelado - Coari |
publisher.none.fl_str_mv |
Brasil ISB - Instituto de Saúde e Biotecnologia (Coari) Coari (AM) Fisioterapia - Bacharelado - Coari |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFAM instname:Universidade Federal do Amazonas (UFAM) instacron:UFAM |
instname_str |
Universidade Federal do Amazonas (UFAM) |
instacron_str |
UFAM |
institution |
UFAM |
reponame_str |
Repositório Institucional da UFAM |
collection |
Repositório Institucional da UFAM |
repository.name.fl_str_mv |
Repositório Institucional da UFAM - Universidade Federal do Amazonas (UFAM) |
repository.mail.fl_str_mv |
|
_version_ |
1798061058718433280 |